Rifampicin induced embryotoxicity in mus musculus.

作者: Chaman Ara , Maha Tahir , Shagufta Andleeb , Ayesha Zafar , Asmatullah

DOI:

关键词:

摘要: During this study, an anti-tuberculosis drug, rifampicin was tested for its embryotoxicity in mice. For purpose, different concentrations of the drug 0.00, 3.00, 6.00 and 12.00 μg/g B.W. were given orally to pregnant mothers on days 6-12 gestation repeatedly fetuses recovered day 18 gestation. Morphological studies showed abnormalities such as hemorrhage, hydrocephaly, microphthalmia, limb deformities (forelimb micromelia hyperextension, drooping wrist, low set arm, hindlimb dysplasia), scoliosis, sacral hygroma, open eyelids curly tail. Dose dependent intrauterine growth retardation also observed. Morphometric indicated fetal body weight CR length, head circumference, eye forelimb size tail length had a significant (P<0.001) dose reduction compared control fetuses. Histological defects included neural tube defects, pericardial hemorrhage hepatic necrosis. By study it is concluded that potential toxic developing

参考文章(20)
Helmuth Vorherr, Drug excretion in breast milk. Postgraduate Medicine. ,vol. 56, pp. 97- 104 ,(1974) , 10.1080/00325481.1974.11713872
John D. Bancroft, Marilyn Gamble, Theory and Practice of Histological Techniques ,(1990)
W R Outman, R E Levitz, D A Hill, C H Nightingale, Intraocular penetration of rifampin in humans. Antimicrobial Agents and Chemotherapy. ,vol. 36, pp. 1575- 1576 ,(1992) , 10.1128/AAC.36.7.1575
G. Acocella, Clinical pharmacokinetics of rifampicin. Clinical Pharmacokinectics. ,vol. 3, pp. 108- 127 ,(1978) , 10.2165/00003088-197803020-00002
Chhinder Pal Sodhi, Satyavati Rana, Saroj Mehta, Kim Vaiphei, Ramesh Chand Goel, Satish Kumar Mehta, Study of oxidative-stress in rifampicin-induced hepatic injury in growin rats with and without protein-energy malnutrition Human & Experimental Toxicology. ,vol. 16, pp. 315- 321 ,(1997) , 10.1177/096032719701600604
Shrutidevi Agrawal, Ramesh Panchagnula, Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms Biopharmaceutics & Drug Disposition. ,vol. 26, pp. 321- 334 ,(2005) , 10.1002/BDD.464
Anne M. Baciewicz, Update on Rifampin Drug Interactions Archives of Internal Medicine. ,vol. 147, pp. 565- 2458 ,(1987) , 10.1001/ARCHINTE.1987.00370030169033
K. Venkatesan, Clinical pharmacokinetic considerations in the treatment of patients with leprosy. Clinical Pharmacokinectics. ,vol. 16, pp. 365- 386 ,(1989) , 10.2165/00003088-198916060-00003
Abhijit Sinha Roy, Ocular malformation following ethambutol, rifampicin, isoniazide in the first trimester of pregnancy Indian Journal of Pediatrics. ,vol. 57, pp. 730- 731 ,(1990) , 10.1007/BF02728726